MedQuist Inc. Announces Appointment Of Two New Officers

MT. LAUREL, N.J., Nov. 23 /PRNewswire-FirstCall/ -- MedQuist Inc. (MEDQ.PK) announced the appointment of two new officers to the MedQuist senior management team.

On November 29, 2004, Terry Cameron will join the Company as senior vice president of marketing and business development. Terry joins the Company from Ingenix, Inc. (a United Healthcare Company), where he had a similar position leading Ingenix to great success via new product planning, market research, alliancing and acquisition activities. Prior to his Ingenix experience, Terry was a vice president at Medicode, executive director of Washington University’s Practice Plan, and director of revenue cycle management of the Duke University Health System.

On November 30, 2004, Jim Weiland will join the Company as the senior vice president of sales to lead the Company’s newly combined sales force. Jim comes to MedQuist from Cardinal Health, Inc., where he was vice president of corporate solutions. Jim has an extensive career spanning over twenty years of leadership in healthcare sales, finance and operations with American Hospital Supply, Baxter, Allegiance Healthcare and, most recently, Cardinal Health. Jim has been recognized as a top performer and results driven leader in each of his assignments.

About MedQuist:

MedQuist is a leading provider of electronic medical transcription, health information and document management services. MedQuist provides document workflow management, digital dictation, speech recognition, mobile dictation devices, Web-based transcription, electronic signature, medical coding products and outsourcing services. MedQuist is a member of the Philips Group of Companies.

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist’s business which are not historical facts are “forward-looking statement” that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward- looking statements, see “Risk Factors” in the Company’s Annual Report or Form 10-K for the most recently ended fiscal year.

Contact: Jim Kirk Ruder Finn Corporate & Financial 212.715.1671kirkj@RuderFinn.com

MedQuist Inc.

CONTACT: Jim Kirk of Ruder Finn Corporate & Financial, +1-212-715-1671,kirkj@RuderFinn.com, for MedQuist Inc.